Somaxon Pharmaceuticals Shares Increase 30 Percent

Shares of Somaxon Pharmaceuticals jumped 30 percent after Chief Executive Rich Pascoe said the company is continuing to work toward approval of an insomnia drug that regulators turned away last month.
SignOnSanDiego